Title | Type | SJR | H index | Total Docs. (2016) | Total Docs. (3years) | Total Refs. (2016) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2016) | %Female (2016) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10 | Journal of Experimental Pharmacology | journal | 0.162 Q3 | 23 | 8 | 6 | 369 | 8 | 6 | 0.80 | 46.13 | 26.92 | |
9 | Drug Safety - Case Reports | journal | 0.241 Q3 | 3 | 1 | 2 | 102 | 2 | 2 | 1.00 | 102.00 | 100.00 | |
8 | Open Access Journal of Clinical Trials | journal | 0.305 Q3 | 15 | 6 | 27 | 162 | 24 | 25 | 0.54 | 27.00 | 27.27 | |
7 | Therapeutics and Clinical Risk Management | journal | 0.765 Q2 | 70 | 211 | 378 | 8586 | 940 | 365 | 2.55 | 40.69 | 34.84 | |
6 | Vascular Health and Risk Management | journal | 0.912 Q2 | 82 | 52 | 213 | 2739 | 647 | 206 | 3.11 | 52.67 | 30.85 | |
5 | Clinical Pharmacology: Advances and Applications | journal | 0.941 Q2 | 34 | 19 | 62 | 1003 | 183 | 58 | 3.24 | 52.79 | 26.14 | |
4 | OncoTargets and Therapy | journal | 0.990 Q2 | 86 | 768 | 890 | 29254 | 2692 | 881 | 2.86 | 38.09 | 38.34 | |
3 | Biologics: Targets and Therapy | journal | 1.133 Q1 | 47 | 18 | 65 | 1047 | 276 | 63 | 3.76 | 58.17 | 43.75 | |
2 | Infection and Drug Resistance | journal | 1.551 Q1 | 65 | 33 | 101 | 1683 | 449 | 101 | 4.89 | 51.00 | 36.27 | |
1 | Perspectives in Medicinal Chemistry | journal | 2.425 Q1 | 17 | 2 | 8 | 277 | 83 | 8 | 10.38 | 138.50 | 40.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®